Press Releases from Tay-Sachs Disease Therapeutics- Pharma Proff (1 total)
Tay-Sachs Disease Therapeutics- Pipeline Analysis 2018, Clinical Trials & Result …
Tay-Sachs is a lysosomal storage disorder caused by the deficiency of vital enzymes called beta-hexosaminidase A (Hex-A). The role of Hex-A is to degrade a…
Go To Page:
